- Home
- BNR vs PIII Comparison
BNR vs PIII Comparison
Compare BNR & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNR | PIII |
|---|---|---|
| Founded | 2014 | 2015 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.7M | 17.1M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | BNR | PIII |
|---|---|---|
| Price | $21.68 | $4.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.25 |
| AVG Volume (30 Days) | ★ 75.1K | 10.7K |
| Earning Date | 11-20-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $75,749,382.00 | ★ $1,444,952,000.00 |
| Revenue This Year | $136.32 | N/A |
| Revenue Next Year | N/A | $12.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5.56 | N/A |
| 52 Week Low | $2.18 | $4.01 |
| 52 Week High | $23.59 | $14.50 |
Technical Indicators
Market Signals| Indicator | BNR | PIII |
|---|---|---|
| Relative Strength Index (RSI) | 63.25 | 21.04 |
| Support Level | $15.71 | $5.01 |
| Resistance Level | $18.42 | $5.20 |
| Average True Range (ATR) | 1.93 | 0.22 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 75.97 | 2.48 |
Price Performance
Historical ComparisonAbout BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.